The US data continues to be going in the right direction with cases decreased by another 10% this past week.

Over last weekend, the US FDA and CDC jointly announced lifting the “pause” on the use of the Johnson & Johnson COVID-19 vaccine.

After 5 consecutive weeks of a slow upward trend in U.S. cases, we have seen nearly a 12% drop in the case rates over the previous week.

The CDC and FDA recommended an immediate pause in the use of the Johnson & Johnson single dose COVID-19 vaccine.

In the United States, the nation is still on track to be able to deliver the vaccine to all willing adults over the next 4 to 6 weeks.

The CDC announced data regarding the efficacy of the major vaccines against infections and infectiousness exceeds 90%.